CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websitearavis.ch
Twitter@AravisSA
Phone+41 43 499 2000
Emailinfo@aravis.ch
Employees
Founded2001
Descriptionventure company

Funds

Offices

HQ
Merkurstrasse 70
Zuerich, CH-8032, CHE

People

Tags

Aravis Ventures

Aravis Ventures is a financial organisation which targets its investments in the fields of life sciences and renewable energy. Their investments are focused in Europe, Asia and North America.

Recent Milestones

Investments

Company Date Round Size Participants
Telormedix 2/12Series B$8.3M2
Synosia Therapeutics 10/10Series C$30M7
MerLion Pharmaceuticals 10/10Series C$7M3
Evolva 12/09Series B$27.5M4
NovImmune 5/09Series D$54.8M7
Ambrx 4/09Series D$10M7
Synosia Therapeutics 1/09Series B$29M7
S*Bio 10/08Venture Round$26M6
Omeros 2/07Series E$63M8
Borean Pharma 3/05Series A€4M4

Videos

Sources

  1. Telormedix, SA.: Series B $8.3M (onbiovc.com) [edit]
  2. Synosia Therapeutics Raises $30M in Series C Financing (synosia.com) [edit]
  3. MerLion Pharmaceuticals Pte. Ltd.: Series C $7M (onbiovc.com) [edit]
  4. Evolva, SA: Series B $27.5M (onbiovc.com) [edit]
  5. NovImmune, SA: Series C $54.8M (onbiovc.com) [edit]
  6. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
  7. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
  8. Capital Report Index [edit]
  9. Omeros Raises More Than $63 Million in Financing (investor.omeros.com) [edit]
  10. Borean Pharma raises Euros 4 Million in series A fundraising (bioportfolio.com) [edit]
Edit This Page
Last Edited 4/23/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

Recent Incoming Links

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy